Abstract

Small extracellular vesicles (small EVs) are commonly released by all cells, and are found in all body fluids. They are implicated in cell to cell short- and long-distance communication through the transfer of genetic material and proteins, as well as interactions between target cell membrane receptors and ligands anchored on small EV membrane. Beyond their canonical functions in healthy tissues, small EVs are strategically used by tumors to communicate with the cellular microenvironment and to establish a proper niche which would ultimately allow cancer cell proliferation, escape from the immune surveillance, and metastasis formation. In this review, we highlight the effects of hematological malignancy-derived small EVs on immune and stromal cells in the tumor microenvironment.

Highlights

  • Our review follows the “Minimal information for studies of extracellular vesicles 2018(MISEV2018)” updated guidelines [1]

  • This effect is highly decreased if the Acute Promyelocytic Leukemia (APML) cells are treated with all-trans retinoic acid (ATRA), a PML-RARα antagonist typically used in the clinic [219]

  • Through the multiple strategies and tools deployed by cancer cells to gain proliferative and survival advantages, small extracellular vesicles are one of the most concealed

Read more

Summary

Introduction

Our review follows the “Minimal information for studies of extracellular vesicles 2018. Considered a physiological phenomenon to remove cellular waste, today, small EVs are considered to be a sophisticated way for cells to communicate with the surrounding microenvironment [7,11]. Their molecular content is strictly dependent on the cell of origin [10]. It was shown that tumor-derived small EVs (TEVs) carry a cargo of molecules that is different from the small EVs released by the healthy counterpart [10]. Cells 2019, 8, 511 that tumor cells release specific small EVs containing an unique molecular fingerprint which is used by tumors to increase proliferation [12], metastasis formation [12,13] and immune escape [14], effectively reshaping the healthy microenvironment in favor of a pro-tumorigenic one

Architecture and Content
The Complex Interactions between TEVs and Cells in the Microenvironment
TEVs as Potential Biomarkers
Hematological Malignancy-Derived Small EVs and Immune Cells
B Cells
T Cells
Dendritic Cells
Natural Killer Cells
Monocytes
Macrophages
Granulocytes
Myeloid-Derived Suppressor Cells
Hematological Malignancies-Derived Small EVs and Stromal Cells
Fibroblasts
Mesenchymal Stem Cells
Endothelial Cells
Osteoblasts and Osteoclasts
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call